MedPath

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

Not Applicable
Recruiting
Conditions
Chronic Pain
Registration Number
NCT04662905
Lead Sponsor
Saluda Medical Pty Ltd
Brief Summary

The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
    1. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication.
    1. Subject is willing and capable of giving informed consent and able to comply with study-related requirements.
Exclusion Criteria

N/A

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in Evoke Compound Action Potentials (ECAPs) as measured by the Evoke SCS SystemThrough study completion, up to 2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (23)

ACT Pain Centre

🇦🇺

Garran, Australian Capital Territory, Australia

Sydney Pain Specialists

🇦🇺

Bella Vista, New South Wales, Australia

Genesis Research Services

🇦🇺

Broadmeadow, New South Wales, Australia

Northern Integrated Pain Management

🇦🇺

Charlestown, New South Wales, Australia

Australian Medical Research

🇦🇺

Hurstville, New South Wales, Australia

Inner West Pain Centre

🇦🇺

Newtown, New South Wales, Australia

Royal North Shore Hospital

🇦🇺

Saint Leonards, New South Wales, Australia

Northern Pain Centre

🇦🇺

St Leonards, New South Wales, Australia

Women's Health & Research Institute of Australia

🇦🇺

Sydney, New South Wales, Australia

Sydney Pain Research Centre Pty Ltd

🇦🇺

Wahroonga, New South Wales, Australia

Scroll for more (13 remaining)
ACT Pain Centre
🇦🇺Garran, Australian Capital Territory, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.